Study links migraine drug to higher kidney stone risk

04/9/2013 | MedPage Today (free registration)

Taking the migraine drug topiramate was associated with lower urinary citrate excretion, putting patients at risk for kidney stones, according to a study presented at the National Kidney Foundation 2013 Spring Clinical Meetings. "Hypocitraturia from topiramate is rapid and progressive," researcher Allan Jhagroo said. "This should be taken into account when starting therapy, particularly in patients with a history of urolithiasis or with identifiable lithogenic risk factors."

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC